Jonathan D. Grinstein, PhD
@grinsteinj
Scientist turned storyteller. North American Editor @inside_pm. for story leads: [email protected]
ID: 734565942697414656
http://jonathandgrinstein.com 23-05-2016 02:05:43
388 Tweet
408 Followers
110 Following
Tomas Babak is a risk-averse drug developer. That's why he developed a clinically optimized driver-associated pharmacogenomics platform for shelved phase 2 drugs to hit solid tumor markets quickly & at a discount and launched Leapfrog Bio. insideprecisionmedicine.com/topics/oncolog… via Inside Precision Medicine